Journal article 782 views 86 downloads
“I would never go to the doctor and speak about steroids”: Anabolic androgenic steroids, stigma and harm
Drugs: Education, Prevention and Policy, Pages: 1 - 13
Swansea University Author: Luke Cox
-
PDF | Version of Record
© 2024 the author(s). This is an open access article distributed under the terms of the creative commons attribution-noncommercial-noDerivatives license ,which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in anyway.
Download (1.63MB)
DOI (Published version): 10.1080/09687637.2024.2373056
Abstract
Background This investigation explores the concept of stigma related to people who use anabolic-androgenic steroids (PWU-AAS) when accessing healthcare services. Anabolic-androgenic steroids (AAS) are used by subsections of the population and have been associated with various health harms. Respondin...
Published in: | Drugs: Education, Prevention and Policy |
---|---|
ISSN: | 0968-7637 1465-3370 |
Published: |
Informa UK Limited
2024
|
Online Access: |
Check full text
|
URI: | https://cronfa.swan.ac.uk/Record/cronfa66902 |
first_indexed |
2024-06-27T09:45:23Z |
---|---|
last_indexed |
2024-12-04T19:45:32Z |
id |
cronfa66902 |
recordtype |
SURis |
fullrecord |
<?xml version="1.0"?><rfc1807><datestamp>2024-12-04T15:46:43.6637174</datestamp><bib-version>v2</bib-version><id>66902</id><entry>2024-06-27</entry><title>“I would never go to the doctor and speak about steroids”: Anabolic androgenic steroids, stigma and harm</title><swanseaauthors><author><sid>9811ac84cad867903c385bf7086dfd2d</sid><ORCID>0000-0001-7625-4603</ORCID><firstname>Luke</firstname><surname>Cox</surname><name>Luke Cox</name><active>true</active><ethesisStudent>false</ethesisStudent></author></swanseaauthors><date>2024-06-27</date><deptcode>EAAS</deptcode><abstract>Background This investigation explores the concept of stigma related to people who use anabolic-androgenic steroids (PWU-AAS) when accessing healthcare services. Anabolic-androgenic steroids (AAS) are used by subsections of the population and have been associated with various health harms. Responding to associated health risks, within the UK, harm reduction and healthcare service provisions have been established. Although these services provide essential support, various barriers, including stigma, exist which can limit engagement with them.Method Ten qualitative interviews were conducted with PWU-AAS and have accessed healthcare and harm reduction services related to their use of AAS.Results PWU-AAS anticipated stigma: (1) when accessing needle and syringe programs; (2) when seeking support from healthcare professionals; and (3) when experiencing specific adverse health implications. Stigma meant PWU-AAS were less likely to engage with healthcare professionals, attend harm reduction services, and were reluctant to disclose specific medial conditions.Conclusions Interventions and messaging tackling AAS-related stigma ought to be considered for public-facing health and harm reduction services, to better support the needs and requirements of PWU-AAS.</abstract><type>Journal Article</type><journal>Drugs: Education, Prevention and Policy</journal><volume>0</volume><journalNumber/><paginationStart>1</paginationStart><paginationEnd>13</paginationEnd><publisher>Informa UK Limited</publisher><placeOfPublication/><isbnPrint/><isbnElectronic/><issnPrint>0968-7637</issnPrint><issnElectronic>1465-3370</issnElectronic><keywords>Keywords: Anabolic androgenic steroids, image and performance enhancing drugs, stigma, harm reduction, needle and syringe program</keywords><publishedDay>14</publishedDay><publishedMonth>7</publishedMonth><publishedYear>2024</publishedYear><publishedDate>2024-07-14</publishedDate><doi>10.1080/09687637.2024.2373056</doi><url/><notes/><college>COLLEGE NANME</college><department>Engineering and Applied Sciences School</department><CollegeCode>COLLEGE CODE</CollegeCode><DepartmentCode>EAAS</DepartmentCode><institution>Swansea University</institution><apcterm>SU Library paid the OA fee (TA Institutional Deal)</apcterm><funders>Swansea University</funders><projectreference/><lastEdited>2024-12-04T15:46:43.6637174</lastEdited><Created>2024-06-27T10:43:24.2549457</Created><path><level id="1">Faculty of Science and Engineering</level><level id="2">School of Engineering and Applied Sciences - Sport and Exercise Sciences</level></path><authors><author><firstname>Luke</firstname><surname>Cox</surname><orcid>0000-0001-7625-4603</orcid><order>1</order></author><author><firstname>Timothy</firstname><surname>Piatkowski</surname><order>2</order></author><author><firstname>Jim</firstname><surname>McVeigh</surname><orcid>0000-0001-5319-6885</orcid><order>3</order></author></authors><documents><document><filename>66902__30912__793c9a8409394b2db08eefc4b171aea5.pdf</filename><originalFilename>66902.vor.pdf</originalFilename><uploaded>2024-07-16T10:35:44.8401191</uploaded><type>Output</type><contentLength>1705876</contentLength><contentType>application/pdf</contentType><version>Version of Record</version><cronfaStatus>true</cronfaStatus><documentNotes>© 2024 the author(s). This is an open access article distributed under the terms of the creative commons attribution-noncommercial-noDerivatives license ,which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in anyway.</documentNotes><copyrightCorrect>true</copyrightCorrect><language>eng</language><licence>http://creativecommons.org/licenses/by-nc-nd/4.0/</licence></document></documents><OutputDurs/></rfc1807> |
spelling |
2024-12-04T15:46:43.6637174 v2 66902 2024-06-27 “I would never go to the doctor and speak about steroids”: Anabolic androgenic steroids, stigma and harm 9811ac84cad867903c385bf7086dfd2d 0000-0001-7625-4603 Luke Cox Luke Cox true false 2024-06-27 EAAS Background This investigation explores the concept of stigma related to people who use anabolic-androgenic steroids (PWU-AAS) when accessing healthcare services. Anabolic-androgenic steroids (AAS) are used by subsections of the population and have been associated with various health harms. Responding to associated health risks, within the UK, harm reduction and healthcare service provisions have been established. Although these services provide essential support, various barriers, including stigma, exist which can limit engagement with them.Method Ten qualitative interviews were conducted with PWU-AAS and have accessed healthcare and harm reduction services related to their use of AAS.Results PWU-AAS anticipated stigma: (1) when accessing needle and syringe programs; (2) when seeking support from healthcare professionals; and (3) when experiencing specific adverse health implications. Stigma meant PWU-AAS were less likely to engage with healthcare professionals, attend harm reduction services, and were reluctant to disclose specific medial conditions.Conclusions Interventions and messaging tackling AAS-related stigma ought to be considered for public-facing health and harm reduction services, to better support the needs and requirements of PWU-AAS. Journal Article Drugs: Education, Prevention and Policy 0 1 13 Informa UK Limited 0968-7637 1465-3370 Keywords: Anabolic androgenic steroids, image and performance enhancing drugs, stigma, harm reduction, needle and syringe program 14 7 2024 2024-07-14 10.1080/09687637.2024.2373056 COLLEGE NANME Engineering and Applied Sciences School COLLEGE CODE EAAS Swansea University SU Library paid the OA fee (TA Institutional Deal) Swansea University 2024-12-04T15:46:43.6637174 2024-06-27T10:43:24.2549457 Faculty of Science and Engineering School of Engineering and Applied Sciences - Sport and Exercise Sciences Luke Cox 0000-0001-7625-4603 1 Timothy Piatkowski 2 Jim McVeigh 0000-0001-5319-6885 3 66902__30912__793c9a8409394b2db08eefc4b171aea5.pdf 66902.vor.pdf 2024-07-16T10:35:44.8401191 Output 1705876 application/pdf Version of Record true © 2024 the author(s). This is an open access article distributed under the terms of the creative commons attribution-noncommercial-noDerivatives license ,which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in anyway. true eng http://creativecommons.org/licenses/by-nc-nd/4.0/ |
title |
“I would never go to the doctor and speak about steroids”: Anabolic androgenic steroids, stigma and harm |
spellingShingle |
“I would never go to the doctor and speak about steroids”: Anabolic androgenic steroids, stigma and harm Luke Cox |
title_short |
“I would never go to the doctor and speak about steroids”: Anabolic androgenic steroids, stigma and harm |
title_full |
“I would never go to the doctor and speak about steroids”: Anabolic androgenic steroids, stigma and harm |
title_fullStr |
“I would never go to the doctor and speak about steroids”: Anabolic androgenic steroids, stigma and harm |
title_full_unstemmed |
“I would never go to the doctor and speak about steroids”: Anabolic androgenic steroids, stigma and harm |
title_sort |
“I would never go to the doctor and speak about steroids”: Anabolic androgenic steroids, stigma and harm |
author_id_str_mv |
9811ac84cad867903c385bf7086dfd2d |
author_id_fullname_str_mv |
9811ac84cad867903c385bf7086dfd2d_***_Luke Cox |
author |
Luke Cox |
author2 |
Luke Cox Timothy Piatkowski Jim McVeigh |
format |
Journal article |
container_title |
Drugs: Education, Prevention and Policy |
container_volume |
0 |
container_start_page |
1 |
publishDate |
2024 |
institution |
Swansea University |
issn |
0968-7637 1465-3370 |
doi_str_mv |
10.1080/09687637.2024.2373056 |
publisher |
Informa UK Limited |
college_str |
Faculty of Science and Engineering |
hierarchytype |
|
hierarchy_top_id |
facultyofscienceandengineering |
hierarchy_top_title |
Faculty of Science and Engineering |
hierarchy_parent_id |
facultyofscienceandengineering |
hierarchy_parent_title |
Faculty of Science and Engineering |
department_str |
School of Engineering and Applied Sciences - Sport and Exercise Sciences{{{_:::_}}}Faculty of Science and Engineering{{{_:::_}}}School of Engineering and Applied Sciences - Sport and Exercise Sciences |
document_store_str |
1 |
active_str |
0 |
description |
Background This investigation explores the concept of stigma related to people who use anabolic-androgenic steroids (PWU-AAS) when accessing healthcare services. Anabolic-androgenic steroids (AAS) are used by subsections of the population and have been associated with various health harms. Responding to associated health risks, within the UK, harm reduction and healthcare service provisions have been established. Although these services provide essential support, various barriers, including stigma, exist which can limit engagement with them.Method Ten qualitative interviews were conducted with PWU-AAS and have accessed healthcare and harm reduction services related to their use of AAS.Results PWU-AAS anticipated stigma: (1) when accessing needle and syringe programs; (2) when seeking support from healthcare professionals; and (3) when experiencing specific adverse health implications. Stigma meant PWU-AAS were less likely to engage with healthcare professionals, attend harm reduction services, and were reluctant to disclose specific medial conditions.Conclusions Interventions and messaging tackling AAS-related stigma ought to be considered for public-facing health and harm reduction services, to better support the needs and requirements of PWU-AAS. |
published_date |
2024-07-14T20:32:16Z |
_version_ |
1821348343186456576 |
score |
11.04748 |